Bone graft and mesenchimal stem cells: clinical observations and histological analysis.

Autologous bone, for its osteoconductive, osteoinductive and osteogenetic properties, has been considered to be the gold standard for maxillary sinus augmentation procedures. Autograft procedures bring also some disadvantages: sometimes the limited amount of available intraoral bone makes necessary to obtain bone from an extraoral site, and this carries an associated morbidity. To overcome this problem we started using homologous freeze-dried bone in maxillary sinus augmentation procedures. This bone is industrially processed with γ-irradiation to eliminate its disease transmission potential and it's considered safe, but this treatment also eliminates the osteoinductive and osteogenetic properties, making it just an inert scaffold for regeneration. Mesenchymal stem cells are successfully used in and orthopedic surgery for their amplification potential of healing mechanisms. We assumed that mesenchymal stem cells can restore the osteogenetic and osteoinductive properties in homologous bone grafts. The aim of this study was an histological evaluation of bone regeneration in maxillary sinus elevation using: 1) mesenchymal stem cells engineered freeze-dried bone allografts; 2) freeze-dried bone allografts. Twenty patients (10M, 10F) with a mean age of 55.2 years affected by severe maxillary atrophy were treated with bilateral maxillary sinus floor elevation. For each patient were randomly assigned a "test" side and a "control" side, different from each other exclusively in the composition of the graft material. The "control" sides were composed by corticocancellous freeze-dried bone chips and the "test" sides were composed by corticocancellous freeze-dried bone chips engineered in a bone marrow mesenchymal stem cells concentrate. After three months bone biopsies were performed on the grafts and histological specimens were made in order to evaluate the healed bone from an histological point of view. Histologically all the specimens showed active remodelling signs and all the tissues were free of inflammatory cells. "Control" side specimens showed a substantial persistence of the grafted bone and, with the interposition of connective tissue, a considerable amount of newly formed bone. "Test" side specimens showed a much more represented cellular component compared to the "control" sides. The grafted bone trabeculae, when detectable, were completely imprisoned inside new formed bone, in direct contact with it and without interposition of connective tissue. Freeze-dried bone can be used successfully as graft material in the treatment of maxillary atrophy. The same bone engineered with stem cells showed a greater histological integration potential comparable with autografts histological morphology. Further studies are needed to confirm these hypotheses.